Full year earnings are consistent with guidance given to the market in August 2014.
CCA’s Group Managing Director, Ms Alison Watkins said, “CCA’s earnings have come under significant pressure in recent years driven by structural changes in the marketplace. 2014 has been a year of transition with solid progress made in developing and implementing a range of initiatives to stabilise earnings and return the business to growth.”
- Forums
- ASX - By Stock
- CCL
- Coke vs Pepsi - Some Perspective
CCL
cuscal limited
Add to My Watchlist
0.32%
!
$3.10

Coke vs Pepsi - Some Perspective, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.10 |
Change
-0.010(0.32%) |
Mkt cap ! $593.8M |
Open | High | Low | Value | Volume |
$3.15 | $3.15 | $3.02 | $1.083M | 349.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $3.04 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.14 | 9599 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 400 | 3.020 |
1 | 5000 | 3.000 |
1 | 1700 | 2.990 |
1 | 8500 | 2.970 |
2 | 1858 | 2.960 |
Price($) | Vol. | No. |
---|---|---|
3.150 | 20000 | 1 |
3.380 | 15000 | 1 |
3.600 | 4000 | 1 |
3.800 | 100 | 1 |
0.000 | 0 | 0 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
CCL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online